Indegene Future Growth

Future criteria checks 3/6

Indegene is forecast to grow earnings and revenue by 18.4% and 11.9% per annum respectively. EPS is expected to grow by 17% per annum. Return on equity is forecast to be 17.4% in 3 years.

Key information

18.4%

Earnings growth rate

17.0%

EPS growth rate

Life Sciences earnings growth22.8%
Revenue growth rate11.9%
Future return on equity17.4%
Analyst coverage

Low

Last updated30 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BSE:544172 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202736,0795,7875,2225,7045
3/31/202631,6854,9324,4314,8615
3/31/202528,0343,9713,3294,1505
9/30/202427,0973,7304,3024,377N/A
6/30/202426,5863,560N/AN/AN/A
3/31/202425,8963,3674,9705,077N/A
12/31/202325,4892,9073,8714,100N/A
6/30/202323,9272,487N/AN/AN/A
3/31/202323,0612,6611,1141,302N/A
3/31/202216,6461,6482,7232,970N/A
3/31/20219,8061,8571,5141,720N/A
3/31/20206,436558162223N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 544172's forecast earnings growth (18.4% per year) is above the savings rate (6.7%).

Earnings vs Market: 544172's earnings (18.4% per year) are forecast to grow faster than the Indian market (17.9% per year).

High Growth Earnings: 544172's earnings are forecast to grow, but not significantly.

Revenue vs Market: 544172's revenue (11.9% per year) is forecast to grow faster than the Indian market (10.4% per year).

High Growth Revenue: 544172's revenue (11.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 544172's Return on Equity is forecast to be low in 3 years time (17.4%).


Discover growth companies